Join
Live feed
·
PRReleasevia Quantisnow
Cartesian Therapeutics Inc. logo

Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases

ByQuantisnow·Wall Street's wire, on your screen.
RNAC· Cartesian Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNAC (Cartesian Therapeutics Inc.) and more on Quantisnow.